基于癫痫持续状态流行病学死亡率评分(EMSE)参数构建并验证预测癫痫持续状态30天死亡率的列线图
该研究纳入2013至2021年收治的≥21岁癫痫持续状态(SE)患者698例,30天死亡率为28.9%(202/698)。利用多因素logistic回归系数构建预测30天死亡风险的列线图,除包含转移性实体瘤或AIDS的合并症组外,所有EMSE参数均与30天死亡风险显著升高相关并纳入列线图。列线图经5000次bootstrap重采样内部验证,AUCROC为0.830(95%CI 0.798-0.862),EMSE单独使用为0.777(95%CI 0.742-0.813),列线图校准良好。结论认为基于EMSE参数的列线图在预测SE后30天死亡风险方面似乎优于EMSE单独使用。
要点
- 在698例SE患者中,30天死亡率为28.9%(202/698)。
- 多因素分析中,除包含转移性实体瘤或AIDS的合并症组外,所有EMSE参数均与30天死亡风险显著升高相关并纳入列线图。
- 列线图经5000次bootstrap重采样内部验证,AUCROC为0.830(95%CI 0.798-0.862),EMSE单独使用为0.777(95%CI 0.742-0.813)。
- 列线图区分度良好:30天内死亡患者评分高于存活者的概率为83%,EMSE单独使用为77%。
- 列线图校准良好。
适用人群与场景
- 年龄≥21岁、2013至2021年收治的癫痫持续状态(SE)患者。
研究设计与关键结果
- 研究类型:预测模型开发与验证研究;样本量:698例SE患者;人群:年龄≥21岁、2013至2021年收治的SE患者。
- 30天死亡率为28.9%(202/698)。
- 多因素分析中,除包含转移性实体瘤或AIDS的合并症组外,所有EMSE参数均与30天死亡风险显著升高相关,并纳入列线图。
- 列线图经5000次bootstrap重采样内部验证,AUCROC为0.830(95%CI 0.798-0.862);EMSE单独使用的AUCROC为0.777(95%CI 0.742-0.813)。
- 30天内死亡患者评分高于存活者的概率为83%,EMSE单独使用为77%。
- 列线图校准良好。
证据类型、等级与局限
- 证据类型:预测模型开发与内部验证研究(队列研究)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,基于EMSE参数的列线图在预测SE后30天死亡风险方面似乎优于EMSE单独使用,其区分度和校准度显示出比EMSE单独使用更好的预测准确性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: To develop a nomogram using the parameters of the Epidemiology-Based Mortality Score in Status Epilepticus (EMSE) and to evaluate its accuracy compared with the EMSE alone in the prediction of 30-day mortality in patients with status epilepticus (SE).
METHODS: We included a cohort of patients with SE aged ≥ 21 years admitted from 2013 to 2021. Regression coefficients from the multivariable logistic regression model were used to generate a nomogram predicting the risk of 30-day mortality. Discrimination of the nomogram was evaluated using the area under the receiver operating characteristic curve (AUCROC) with 95% confidence interval. Internal validation was performed by bootstrap resampling.
RESULTS: Among 698 patients with SE, the 30-day mortality rate was 28.9% (202 of 698). On the multivariable analysis, all EMSE parameters (except for the comorbidity group including metastatic solid tumor or AIDS) were associated with a significantly higher risk of 30-day mortality and were included in the nomogram. The discriminatory capability of the nomogram with bootstrap resampling (5000 resamples) had an AUCROC of 0.830 (95% confidence interval 0.798-0.862). Conversely, the AUCROC of the EMSE was 0.777 (95% confidence interval 0.742-0.813). Thus, the probability that a patient who died within 30 days from SE had a higher score than a patient who survived was 83%, indicating good discriminatory power of the nomogram. Conversely, the risk predicted using the EMSE alone was 77%. The nomogram was well calibrated.
CONCLUSIONS: A nomogram based on EMSE parameters appears superior to the EMSE in predicting the risk of 30-day mortality after SE. The discrimination and calibration of the nomogram shows a better predictive accuracy than the EMSE alone.
参考来源
- Brigo F, Turcato G, Lattanzi S, et al. Development and Validation of a Nomogram Based on the Epidemiology-Based Mortality Score in Status Epilepticus (EMSE) Parameters to Predict 30-day Mortality in Status Epilepticus. Neurocrit Care. 2022. PMID: 35778648. doi:10.1007/s12028-022-01548-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。